Centchroman regulates breast cancer angiogenesis via inhibition of HIF‐1&agr;/VEGFR2 signalling axis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Life Science

• Publication date

  2018-01-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.lfs.2017.11.045PMID 29196053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells

  2017cited by this paper
• Salinomycin: A new paradigm in cancer therapy

  2017cited by this paper
• Centchroman induces redox-dependent apoptosis and cell-cycle arrest in human endometrial cancer cells

  2017cited by this paper
• Genistein synergizes centchroman action in human breast cancer cells

  2016cited by this paper
• Ormeloxifene efficiently inhibits ovarian cancer growth.

  2015cited by this paper
• Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.

  2015cited by this paper
• Mammosphere formation assay from human breast cancer tissues and cell lines.

  2015cited by this paper
• Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials

  2014cited by this paper
• Anti-cancer potential of a novel SERM ormeloxifene.

  2013cited by this paper
• Selection of a MCF-7 Breast Cancer Cell Subpopulation with High Sensitivity to IL-1β: Characterization of and Correlation between Morphological and Molecular Changes Leading to Increased Invasiveness

  2012cited by this paper
• Side effects of anti-angiogenic drugs.

  2012cited by this paper
• Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium

  2011cited by this paper
• The Phenotypic Radiation Resistance of CD44+/CD24−or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission

  2011cited by this paper
• Hypoxia-induced angiogenesis: good and evil.

  2011cited by this paper
• Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

  2011cited by this paper
• 2‐D gel electrophoresis‐based proteomic analysis reveals that ormeloxifen induces G0–G1 growth arrest and ERK‐mediated apoptosis in chronic myeloid leukemia cells K562

  2011cited by this paper
• Centchroman inhibits proliferation of head and neck cancer cells through the modulation of PI3K/mTOR pathway.

  2011cited by this paper
• PI3K/AKT/mTOR Pathway in Angiogenesis

  2011cited by this paper
• Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.

  2010cited by this paper
• Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells.

  2008cited by this paper
• AKT signaling in regulating angiogenesis.

  2008cited by this paper
• Review: side effects of approved molecular targeted therapies in solid cancers.

  2007cited by this paper
• Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor.

  2007cited by this paper
• Angiogenesis in Cancer

  2006cited by this paper
• Matrix metalloproteinases and angiogenesis

  2005cited by this paper
• Apigenin Inhibits Expression of Vascular Endothelial Growth Factor and Angiogenesis in Human Lung Cancer Cells: Implication of Chemoprevention of Lung Cancer

  2005cited by this paper
• Regulation of tumor angiogenesis by integrin-linked kinase (ILK).

  2004cited by this paper
• Capsaicin Inhibits in Vitro and in Vivo Angiogenesis

  2004cited by this paper
• Cited Articles Citing Articles E-mail Alerts Capsaicin Inhibits in Vitro and in Vivo Angiogenesis

  2004cited by this paper
• Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase

  2004cited by this paper
• [Angiogenesis in cancer].

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone‐related clinical disorders

  2001cited by this paper
• Matrix metalloproteinases and angiogenesis

  2000cited by this paper
• Involvement of endothelial PECAM-1/CD31 in angiogenesis.

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Angiogenesis: role of calcium-mediated signal transduction.

  1995cited by this paper
• Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

  1988cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• Modulation of breast cancer progression in high-altitude hypoxia by Tongqiaohuoxue Decoction via HIF-1α/VEGF signaling.

  2026cites this paper
• Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics

  2025cites this paper
• Microenvironmental regulation and remodeling of breast cancer angiogenesis: from basic mechanisms to clinical therapeutic implications

  2025cites this paper
• NREP, transcriptionally upregulated by HIF-1α, aggravates breast cancer cell growth and metastasis by promoting glycolysis

  2024cites this paper
• Hypoxic Signaling Pathways in Carotid Body Tumors

  2024cites this paper
• Evaluation of molecular effects associated with apoptosis, tumour progression, angiogenesis and metastasis by a novel combination of drugs with ormeloxifene in triple negative breast cancer cells

  2024cites this paper
• Unleashing the potential: transarterial chemoembolization combined with intra-arterial infusion of bevacizumab for unresectable hepatocellular carcinoma

  2024cites this paper
• Comprehensive analysis of circRNA-miRNA-mRNA network related to angiogenesis in recurrent implantation failure

  2024cites this paper
• Estrogen receptor β affects hypoxia response in colorectal cancer cells.

  2023cites this paper
• COVID-19 Possibly Deteriorates the Conditions of Cancer Patients by Increasing Oxidative Stress

  2022cites this paper
• Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach

  2022cites this paper
• Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment

  2022cites this paper
• Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses

  2021cites this paper
• Non-coding RNAS as Trojan Horse in Eliminating ROS Induced Cancer

  2021cites this paper
• Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells

  2021cites this paper
• Exosomes derived from macrophages upon cobalt ion stimulation promote angiogenesis.

  2021cites this paper
• Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance

  2021cites this paper
• Extracellular Vesicles and Integrins: Partners in Cancer Progression

  2020cites this paper
• Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma.

  2020cites this paper
• Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition.

  2020cites this paper
• Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs.

  2020cites this paper
• Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.

  2020cites this paper
• Three dimensional engineered models to study hypoxia biology in breast cancer.

  2020cites this paper
• Tumorigenesis and Progression As A Consequence of Hypoxic TME：A Prospective View upon Breast Cancer Therapeutic Targets.

  2020cites this paper
• Three new acrylic acid derivatives from Achillea mellifolium as potential thymidine phosphorylase inhibitor: molecular docking and MD simulation studies

  2020cites this paper
• Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo.

  2019cites this paper
• Effect of lincRNA-p21 targeting HIF-1α on biological functions of liver cancer cells

  2019cites this paper
• Safety assessment of the pharmacological excipient, diethylene glycol monoethyl ether (DEGEE), using in vitro and in vivo systems

  2019cites this paper
• The role of hypoxia-induced factor 1�� in breast cancer

  2019influential citation
• AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.

  2019cites this paper
• Genistein potentiates Centchroman induced antineoplasticity in breast cancer via PI3K/Akt deactivation and ROS dependent induction of apoptosis.

  2019cites this paper
• Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line

  2019cites this paper
• Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.

  2019cites this paper
• In vitro assays and techniques utilized in anticancer drug discovery

  2018cites this paper
• Vandetanib (ZD6474) induces antiangiogenesis through mTOr–hiF-1 alpha–VegF signaling axis in breast cancer cells

  2018cites this paper
• Vandetanib (ZD6474) induces antiangiogenesis through mTOr–hiF-1 alpha–VegF signaling axis in breast cancer cells

  2018cites this paper
• Prolactin selectively transported to cerebrospinal fluid from blood under hypoxic/ischemic conditions

  2018cites this paper
• Vandetanib (ZD6474) induces antiangiogenesis through mTOR–HIF-1 alpha–VEGF signaling axis in breast cancer cells

  2018cites this paper
• Nonhormonal selective estrogen receptor modulator 1‐(2‐[4‐{(3R,4S)‐7‐Methoxy‐2, 2‐dimethyl‐3‐phenyl‐chroman‐4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancer

  2018cites this paper
• Peritumoural adipose tissue pro‐inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients

  2018cites this paper
• MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2.

  2018cites this paper
• Modi fi ed methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line

  year unknowncites this paper